摘要 |
<p>The invention relates to a novel pharmaceutical composition useful in the treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD). The composition comprises formoterol, HFA 227, HFA 134a, PVP and PEG.</p> |